Presenting this month: Tetherex & SendaRide
Tetherex is focused on development of an anti-PSGL-1 antibodies for the treatment of inflammatory and thrombotic diseases. The lead indication is a treatment for Crohn’s Disease (CD). In mild to moderate disease Tetherex may improve the symptoms of CD when used in conjunction with medications such as antibiotics, and immunosuppressants to prevent recurrence. There still remains a significant unmet medical need in patients with CD.
SendaRide provides non-emergency medical transportation for the health care industry that is customized to each patient’s needs and provided through their own network of drivers. The technology integrates within the medical software and allows the hospital, provider or health plan to schedule the right-sized transportation when needed, with one-way and round-trip rides for their patients.
